By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IMPAX Laboratories 

30831 Huntwood Avenue

Hayward  California  94544  U.S.A.
Phone: 510-476-2000 Fax: 510-471-3200



Drug Delivery

Company News
IMPAX Labs (IPXL) To Report Third Quarter 2016 Results On November 9, 2016 10/4/2016 9:57:48 AM
IMPAX Labs (IPXL) Launches Generic Version Of Metadate CD (Methylphenidate Hydrochloride Extended-Release Capsules) 9/22/2016 7:06:45 AM
IMPAX Labs (IPXL) To Present At The Morgan Stanley Global Healthcare Conference 9/7/2016 10:54:26 AM
IMPAX Labs (IPXL) Provides Update On Epinephrine Injection, USP Auto-Injector 8/30/2016 9:29:16 AM
IMPAX Labs (IPXL) Issues Voluntary, Nationwide Recall For One Lot Of Lamotrigine Orally Disintegrating Tablet 200 Mg Due To The Potential For 100 Mg Blister Cards Being Packaged In 200 Mg Containers 8/29/2016 8:10:19 AM
Richard A. Bierly Appointed To IMPAX Labs (IPXL) Board Of Directors 8/22/2016 8:04:20 AM
IMPAX Labs (IPXL) Reports Second Quarter 2016 Financial Results 8/9/2016 8:34:53 AM
IMPAX Labs (IPXL) Names Douglas S. Boothe President Of Generics Division 7/22/2016 6:26:10 AM
IMPAX Labs (IPXL) To Report Second Quarter 2016 Results On August 9, 2016 7/7/2016 7:37:20 AM
Bay Area's IMPAX Labs (IPXL) Plunks Down $586 Million for a Chunk of Teva (TEVA) and Allergan (AGN)’s Generics Portfolio 6/21/2016 6:19:07 AM